Abstract
Osteoporosis is a degenerative bone disease that causes significant morbidity and mortality in multiple sclerosis (MS) patients; the pathogenesis of this disease being poorly understood in the context of MS. Osteoporosis is seen more frequently in MS patients than in healthy controls matched for age and sex. Extensively studied factors, including impaired ambulation and the use of steroids, do not appear to completely account for the phenomenon. This review summarizes common risk factors, physiologic and genetic, that may contribute to the etiology and progression of osteoporosis in MS patients as well as providing insight into nervous system control of bone metabolism and homeostasis.
| Original language | English |
|---|---|
| Pages (from-to) | 8-14 |
| Number of pages | 7 |
| Journal | Journal of the Neurological Sciences |
| Volume | 319 |
| Issue number | 1-2 |
| DOIs | |
| State | Published - Aug 15 2012 |
Keywords
- Leptin
- Multiple sclerosis
- Neuromedin U
- Neuropeptide Y
- Osteoporosis
- Serotonin
- Vitamin D
Fingerprint
Dive into the research topics of 'The nervous system's potential role in multiple sclerosis associated bone loss'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver